Copenhagen, Denmark

Claus Aagaard

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • København S, DK (2012)
  • Cophenhagen S, DK (2018)
  • Copenhagen, DK (2011 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Claus Aagaard – Innovator in Tuberculosis Diagnostics and Vaccines

Introduction

Claus Aagaard, located in Copenhagen, Denmark, is an accomplished inventor with a remarkable portfolio of ten patents. His work predominantly focuses on diagnostic reagents and vaccines aimed at combating tuberculosis, showcasing his dedication to advancing medical science.

Latest Patents

Aagaard's latest contributions include inventions that significantly enhance the capabilities of tuberculosis diagnosis. His patent on "Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis" introduces advanced methods that provide increased specificity and sensitivity in detecting the disease. This innovation aims to improve existing diagnostic techniques by utilizing enhanced antigen mixtures that include ESAT-6, allowing for more accurate results.

Additionally, Aagaard is the inventor of a patent related to "M. tuberculosis vaccines," which targets virulent mycobacteria. This invention encompasses the development of a fusion protein, antigen cocktails, and immunological compositions intended to create effective vaccines. The components focus on proteins secreted by the ESAT-6 secretion system 1 (ESX-1), which are known as some of the most immunodominant antigens related to tuberculosis.

Career Highlights

Claus Aagaard is associated with the Statens Serum Institut, a prestigious institution known for its role in public health and research in Denmark. His career is marked by significant contributions to medical innovation, particularly in the realm of infectious diseases.

Collaborations

Aagaard works alongside esteemed colleagues such as Peter Andersen and Carina Vingsbo-Lundberg, fostering a collaborative environment that amplifies their research efforts. Together, they contribute to understanding and combating tuberculosis, leveraging their combined expertise to promote advancements in diagnostics and therapeutic solutions.

Conclusion

Claus Aagaard stands out as a key figure in the fight against tuberculosis, with his inventions poised to make significant impacts on medical diagnostics and vaccines. Through his work at Statens Serum Institut and collaboration with talented coworkers, Aagaard continues to push the boundaries of innovation, striving to improve health outcomes for those affected by this serious infectious disease. His portfolio of patents underscores his commitment to scientific progress and public health advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…